TVTX · Categories · Downgrades

TVTX - Analyst downgrades

Travere Therapeutics Inc. (TVTX) analyst downgrades - real-time wire coverage filtered to Downgrades only.

Recent Downgrades for TVTX

• 817d
  Travere Therapeutics downgraded by Guggenheim

  Guggenheim downgraded Travere Therapeutics from Buy to Neutral
• 1004d
  Travere Therapeutics downgraded by Wells Fargo with a new price target

  Wells Fargo downgraded Travere Therapeutics from Overweight to Equal Weight and set a new price target of $8.00 from $24.00 previously
• 1005d
  Travere Therapeutics downgraded by William Blair

  William Blair downgraded Travere Therapeutics from Outperform to Mkt Perform
• 1853d
  Travere Therapeutics downgraded by Wedbush with a new price target

  Wedbush downgraded Travere Therapeutics from Outperform to Neutral and set a new price target of $19.00

Other TVTX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 4
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings